Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
103.24
-1.59 (-1.52%)
At close: Feb 25, 2026, 4:00 PM EST
92.94
-10.30 (-9.98%)
After-hours: Feb 25, 2026, 5:13 PM EST
Revolution Medicines Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$102.63
Upside
-0.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $92 → $122 | Buy | Maintains | $92 → $122 | +18.17% | Feb 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 → $150 | Buy | Maintains | $75 → $150 | +45.29% | Jan 27, 2026 |
| Stifel | Stifel | Strong Buy Maintains $85 → $170 | Strong Buy | Maintains | $85 → $170 | +64.66% | Jan 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $77 → $140 | Buy | Maintains | $77 → $140 | +35.61% | Jan 21, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $92 → $160 | Strong Buy | Maintains | $92 → $160 | +54.98% | Jan 20, 2026 |
| Mizuho | Mizuho | Buy Maintains $90 → $143 | Buy | Maintains | $90 → $143 | +38.51% | Jan 13, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $75 | Buy | Initiates | $75 | -27.35% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $71 → $82 | Buy | Maintains | $71 → $82 | -20.57% | Nov 6, 2025 |
| Wedbush | Wedbush | Buy Maintains $77 → $80 | Buy | Maintains | $77 → $80 | -22.51% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $66 → $72 | Strong Buy | Maintains | $66 → $72 | -30.26% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $73 | Strong Buy | Maintains | $72 → $73 | -29.29% | Nov 6, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $77 | Buy | Initiates | $77 | -25.42% | Nov 3, 2025 |
| Mizuho | Mizuho | Buy Initiates $90 | Buy | Initiates | $90 | -12.82% | Oct 21, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $72 → $76 | Strong Buy | Maintains | $72 → $76 | -26.39% | Oct 17, 2025 |
| Wedbush | Wedbush | Buy Reiterates $77 | Buy | Reiterates | $77 | -25.42% | Oct 17, 2025 |
| Stifel | Stifel | Strong Buy Initiates $85 | Strong Buy | Initiates | $85 | -17.67% | Oct 16, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.